WASHINGTON — As drug pricing talks in Congress heated up this week, Democrats negotiated in earnest to get skeptics of their drug pricing policies on board.
With crunch time approaching for talks on a major legislative package containing the cornerstone of President Biden’s domestic agenda, drug pricing policy remained unresolved as lawmakers scramble to get consensus on a complicated, contentious issue.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
